SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors
暂无分享,去创建一个
Andrew Emili | Chao Gao | Richard D. Cummings | Nan Jia | Kelan Tantisira | Hua Zhang | A. Emili | R. Cummings | Adam J. Hume | K. Tantisira | E. Mühlberger | Julian H. Kwan | Julian Kwan | K. Stavenhagen | Elke Mühlberger | Irma van Die | I. van Die | Kathrin Stavenhagen | Junwei Zeng | Yasuyuki Matsumoto | Junwei Zeng | Yasuyuki Matsumoto | Jiang Li | A. Hume | Nan Jia | Hua Zhang | Jiang Li | Chao Gao
[1] M. Lotze,et al. DC/L‐SIGNs of hope in the COVID‐19 pandemic , 2020, Journal of medical virology.
[2] V. KewalRamani,et al. Functional Evaluation of DC-SIGN Monoclonal Antibodies Reveals DC-SIGN Interactions with ICAM-3 Do Not Promote Human Immunodeficiency Virus Type 1 Transmission , 2002, Journal of Virology.
[3] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[4] R. Desrosiers,et al. Discovery of O-Linked Carbohydrate on HIV-1 Envelope and Its Role in Shielding against One Category of Broadly Neutralizing Antibodies. , 2020, Cell reports.
[5] W. Mak,et al. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection , 2005, Nature Genetics.
[6] André M Deelder,et al. Site-specific N-glycosylation analysis of human immunoglobulin e. , 2014, Journal of proteome research.
[7] J. Zehnder,et al. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease , 2020, medRxiv.
[8] A. Steinkasserer,et al. DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus , 2004, Journal of Virology.
[9] Daniel Wrapp,et al. Site-specific glycan analysis of the SARS-CoV-2 spike , 2020, Science.
[10] Paul J. Hoffman,et al. Comprehensive Integration of Single-Cell Data , 2018, Cell.
[11] M. Merad,et al. Immunology of COVID-19: Current State of the Science , 2020, Immunity.
[12] Haibo Xu,et al. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer , 2020, Journal of Thoracic Oncology.
[13] Hans Clevers,et al. SARS-CoV-2 productively infects human gut enterocytes , 2020, Science.
[14] R. Cummings,et al. The Human Lung Glycome Reveals Novel Glycan Ligands for Influenza A Virus , 2020, Scientific Reports.
[15] B. Meyer,et al. Tumor-associated Neu5Ac-Tn and Neu5Gc-Tn antigens bind to C-type lectin CLEC10A (CD301, MGL). , 2013, Glycobiology.
[16] S. Gringhuis,et al. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori , 2009, Nature Immunology.
[17] R. Lu,et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.
[18] Y. Lau,et al. Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells , 2005, Blood.
[19] Yuan Guo,et al. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR , 2004, Nature Structural &Molecular Biology.
[20] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[21] Kentaro Kato,et al. Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3 , 2020, Nature Chemical Biology.
[22] Miriam Merad,et al. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages , 2020, Nature Reviews Immunology.
[23] A. Molinaro,et al. Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2 Spike Protein to Host Lectins and Lung Microbiota , 2020, bioRxiv.
[24] H. Shan,et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples , 2020, The Lancet Gastroenterology & Hepatology.
[25] Anne Kimball,et al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.
[26] Melinda S. Hanes,et al. Unique Binding Specificities of Proteins toward Isomeric Asparagine-Linked Glycans. , 2019, Cell chemical biology.
[27] M. Cho,et al. Specific Asparagine-Linked Glycosylation Sites Are Critical for DC-SIGN- and L-SIGN-Mediated Severe Acute Respiratory Syndrome Coronavirus Entry , 2007, Journal of Virology.
[28] E. Chiffoleau,et al. C-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity , 2020, Frontiers in Immunology.
[29] S. Ng,et al. Impact of host cell line choice on glycan profile , 2018, Critical reviews in biotechnology.
[30] Douglas S Kwon,et al. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.
[31] Samuel L. Wolock,et al. A Single-Cell Transcriptomic Map of the Human and Mouse Pancreas Reveals Inter- and Intra-cell Population Structure. , 2016, Cell systems.
[32] Yuzhang Wu,et al. The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes , 2020, medRxiv.
[33] Y. Kooyk. C-type lectins on dendritic cells: key modulators for the induction of immune responses. , 2008 .
[34] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[35] R. Cummings,et al. Glycosylation of Zika Virus is Important in Host–Virus Interaction and Pathogenic Potential , 2019, International journal of molecular sciences.
[36] Fabian J Theis,et al. SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.
[37] Kuan-Hsuan Chen,et al. Identifying Epitopes Responsible for Neutralizing Antibody and DC-SIGN Binding on the Spike Glycoprotein of the Severe Acute Respiratory Syndrome Coronavirus , 2006, Journal of Virology.
[38] L. Martínez-Pomares. The mannose receptor , 2012, Journal of leukocyte biology.
[39] David F. Smith,et al. Human DC-SIGN binds specific human milk glycans. , 2016, The Biochemical journal.
[40] Masahiro Yoshida,et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes , 2020, Nature Medicine.
[41] Larissa B. Thackray,et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[42] Martin Stahl,et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 , 2020, Cell.
[43] Judy H. Cho,et al. Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy , 2019, Cell.
[44] David F. Smith,et al. Identification of Tn Antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies. , 2019, Glycobiology.
[45] Fabian J Theis,et al. A cellular census of human lungs identifies novel cell states in health and in asthma , 2019, Nature Medicine.
[46] P. Puigserver,et al. Foxa2, a novel transcriptional regulator of insulin sensitivity , 2006, Nature Medicine.
[47] Aviv Regev,et al. Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis , 2019, Cell.
[48] Sara Invitto,et al. Current state of the science , 2015 .
[49] W. Weis,et al. Structural Basis for Selective Recognition of Oligosaccharides by DC-SIGN and DC-SIGNR , 2001, Science.
[50] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[51] Ricardo J. Miragaia,et al. scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation , 2019, Genome Biology.
[52] K. Subbarao,et al. pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN , 2004, Journal of Virology.
[53] Andrea Marzi,et al. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.
[54] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[55] Yvan Saeys,et al. A cell atlas of human thymic development defines T cell repertoire formation , 2020, Science.
[56] Nan Tang,et al. SARS-CoV-2 and viral sepsis: observations and hypotheses , 2020, The Lancet.
[57] Lucy A. Perrone,et al. Severe Acute Respiratory Syndrome and the Innate Immune Responses: Modulation of Effector Cell Function without Productive Infection1 , 2005, The Journal of Immunology.
[58] Y. Kooyk,et al. Protein-glycan interactions in the control of innate and adaptive immune responses , 2008, Nature Immunology.
[59] Daniel Wrapp,et al. Site-specific analysis of the SARS-CoV-2 glycan shield , 2020, bioRxiv.
[60] Lin Cheng,et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 , 2020, Nature Medicine.
[61] Asif Shajahan,et al. Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 , 2020, Glycobiology.
[62] D. Pe’er,et al. A single-cell atlas of the human healthy airways , 2019, bioRxiv.